GEP20125516B - Therapeutic uses of inhibitors of rtp801 - Google Patents
Therapeutic uses of inhibitors of rtp801Info
- Publication number
- GEP20125516B GEP20125516B GEAP2005009869A GEP20125516B GE P20125516 B GEP20125516 B GE P20125516B GE AP2005009869 A GEAP2005009869 A GE AP2005009869A GE P20125516 B GEP20125516 B GE P20125516B
- Authority
- GE
- Georgia
- Prior art keywords
- rtp801
- inhibitors
- therapeutic uses
- rnk
- respiratory
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 101000912753 Homo sapiens DNA damage-inducible transcript 4 protein Proteins 0.000 abstract 1
- 108020004459 Small interfering RNA Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000030533 eye disease Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The novel compound of interference siRNA RNK molecule, pharmaceutical composition containing it and its use for treating eye diseases or respiratory or microvascular disorders based upon inhibition of the RTP801 gene and/or protein.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04019405 | 2004-08-16 | ||
| US60198304P | 2004-08-17 | 2004-08-17 | |
| US60466804P | 2004-08-25 | 2004-08-25 | |
| US60978604P | 2004-09-14 | 2004-09-14 | |
| US63865904P | 2004-12-22 | 2004-12-22 | |
| US66423605P | 2005-03-22 | 2005-03-22 | |
| US68894305P | 2005-06-08 | 2005-06-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP20125516B true GEP20125516B (en) | 2012-05-25 |
Family
ID=39085993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP2005009869 GEP20125516B (en) | 2004-08-16 | 2005-08-16 | Therapeutic uses of inhibitors of rtp801 |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN102847154A (en) |
| DK (1) | DK1791568T3 (en) |
| ES (2) | ES2691196T3 (en) |
| GE (1) | GEP20125516B (en) |
| UA (1) | UA92465C2 (en) |
| ZA (1) | ZA200701364B (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1009753B1 (en) * | 1997-08-21 | 2005-04-20 | Quark Biotech, Inc. | Hypoxia-regulated genes |
| US20070178090A1 (en) * | 2003-04-01 | 2007-08-02 | Genzyme Corporation | Breast endothelial cell expression patterns |
| JP2005095173A (en) * | 2003-09-04 | 2005-04-14 | Masaomi Nangaku | Method for detection of hypoxia response |
| JP2007512369A (en) * | 2003-11-26 | 2007-05-17 | エンテロス・インコーポレーテッド | Treatment of rheumatoid arthritis with hypoxia-inducible factor 1α antagonist |
| EP1709175A2 (en) * | 2003-12-03 | 2006-10-11 | Corgentech, Inc. | Hif oligonucleotide decoy molecules |
-
2005
- 2005-08-16 CN CN2012103379415A patent/CN102847154A/en active Pending
- 2005-08-16 DK DK05786796.2T patent/DK1791568T3/en active
- 2005-08-16 ES ES11153604.1T patent/ES2691196T3/en active Active
- 2005-08-16 ES ES05786796T patent/ES2390085T3/en active Active
- 2005-08-16 UA UAA200701610A patent/UA92465C2/en unknown
- 2005-08-16 GE GEAP2005009869 patent/GEP20125516B/en unknown
-
2007
- 2007-02-15 ZA ZA200701364A patent/ZA200701364B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102847154A (en) | 2013-01-02 |
| ES2390085T3 (en) | 2012-11-06 |
| ZA200701364B (en) | 2008-04-30 |
| DK1791568T3 (en) | 2012-12-10 |
| UA92465C2 (en) | 2010-11-10 |
| ES2691196T3 (en) | 2018-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006023544A3 (en) | Therapeutic uses of inhibitors of rtp801 | |
| ATE442142T1 (en) | FREDERICAMYCIN DERIVATIVES AS DRUGS FOR TUMOR TREATMENT | |
| TW200806325A (en) | Therapeutic uses of inhibitors of RTP801 | |
| WO2007141796A3 (en) | Therapeutic uses of inhibitors of rtp801l | |
| TW200508214A (en) | Novel compounds | |
| GEP20094845B (en) | Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors | |
| DE50310516D1 (en) | Fredericamycin DERIVATIVES | |
| IL181987A0 (en) | Diaminotriazole derivatives and pharmaceutical compositions containing the same | |
| IL182218A0 (en) | Preparation and use of biphenyl-4-yl-carbonylamino and derivatives for the treatment of obesity | |
| TW200608979A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
| IL196543A (en) | Pyridazinone derivatives and pharmaceutical compositions comprising them for use in the treatment of disorders | |
| TW200510334A (en) | Preraration and use of aryl alkyl acid derivatives for the treatment of obesity | |
| MY162157A (en) | Substituted indole mcl-1 inhibitors | |
| WO2005046603A3 (en) | Pyridine compounds | |
| WO2003080582A3 (en) | Fredericamycin derivatives | |
| TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
| MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
| TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| TW200738659A (en) | Novel compounds | |
| EA200800011A1 (en) | THYENOPYRIMIDINE AND THYENOPYRIDINE KINASE MODULATORS | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| TW200740808A (en) | Inhibiteurs de proteines kinases | |
| EA201170344A1 (en) | AZAINDOL IAP INHIBITORS | |
| ATE496899T1 (en) | TETRAHYDRO- AND DIHYDROQUINAZOLINONES | |
| GEP20125516B (en) | Therapeutic uses of inhibitors of rtp801 |